Novel Jnk Inhibitors

Abstract

Disclosed are compounds of the formula (I) wherein X is N or CH, and Y is N or CR<SUP>5</SUP>. Also disclosed are methods of treating JNK and ERK mediated diseases using the compounds of formula 1.0.


Claims
IPC Classifications

Download Citation


Sign in to the Lens

Feedback